Adjuvant therapy for high-risk melanoma

Por Eggermont, Alexander M.M.
Publicado em 2013

Novel immune checkpoint blocker approved for the treatment of advanced melanoma

Por Galluzzi, Lorenzo, Kroemer, Guido, Eggermont, Alexander
Publicado no Oncoimmunology (2014)

Doubling the blockade for melanoma immunotherapy

Por Galluzzi, Lorenzo, Eggermont, Alexander, Kroemer, Guido
Publicado no Oncoimmunology (2015)

Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms

Por Lehmann, Frederic, Lacombe, Denis, Therasse, Patrick, Eggermont, Alexander MM
Publicado em 2003

Regional cancer therapy

Por Schlag, Peter M., Stein, Ulrike S., Eggermont, Alexander M. M.
Publicado em c200

Harnessing the immune system to provide long-term survival in patients with melanoma and other solid tumors

Por Eggermont, Alexander, Robert, Caroline, Soria, Jean Charles, Zitvogel, Laurence
Publicado em 2014

Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy

Por Champiat, Stéphane, Ferté, Charles, Lebel-Binay, Sophie, Eggermont, Alexander, Soria, Jean Charles
Publicado em 2014

Metastatic melanoma: New paradigms of treatment and new toxicities

Por Robert, Caroline, Mateus, Christina, Routier, Emilie, Thomas, Marina, Boussemart, Lise, Eggermont, Alexander M.
Publicado em 2013

Potential Cost-Effectiveness of US-Guided FNAC in Melanoma Patients as a Primary Procedure and in Follow-Up

Por van Akkooi, Alexander C. J., Voit, Christiane A., Verhoef, Cornelis, Eggermont, Alexander M. M.
Publicado em 2009

Trial Watch: Immunostimulatory cytokines

Por Vacchelli, Erika, Galluzzi, Lorenzo, Eggermont, Alexander, Galon, Jerome, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido
Publicado em 2012

Trial Watch: Lenalidomide-based immunochemotherapy

Por Semeraro, Michaela, Vacchelli, Erika, Eggermont, Alexander, Galon, Jerome, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado em 2013

Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid Tumors

Por Koning, Gerben A., Eggermont, Alexander M. M., Lindner, Lars H., ten Hagen, Timo L. M.
Publicado em 2010

Trial watch: Monoclonal antibodies in cancer therapy

Por Vacchelli, Erika, Eggermont, Alexander, Galon, Jérôme, Sautès-Fridman, Catherine, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado em 2013

Trial watch: Oncolytic viruses for cancer therapy

Por Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado em 2013

Trial Watch: Immunostimulatory cytokines

Por Vacchelli, Erika, Eggermont, Alexander, Fridman, Wolf Hervé, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado em 2013

Trial Watch: Toll-like receptor agonists for cancer therapy

Por Vacchelli, Erika, Eggermont, Alexander, Sautès-Fridman, Catherine, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado em 2013

Factors Influencing Prognosis After Initial Inadequate Excision (IIE) for Soft Tissue Sarcoma

Por Van Geel, Albert N., Eggermont, Alexander M. M., Hanssens, Patrick E. J., Schmitz, Paul I. M.
Publicado em 2003

Trial watch: Cardiac glycosides and cancer therapy

Por Menger, Laurie, Vacchelli, Erika, Kepp, Oliver, Eggermont, Alexander, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Publicado em 2013

Dendritic cell–derived exosomes for cancer therapy

Por Pitt, Jonathan M., André, Fabrice, Amigorena, Sebastian, Soria, Jean-Charles, Eggermont, Alexander, Kroemer, Guido, Zitvogel, Laurence
Publicado no J Clin Invest (2016)

Giant solitary fibrous tumour of the liver

Por Terkivatan, Türkan, Kliffen, Mike, de Wilt, Johannes HW, van Geel, Albertus N, Eggermont, Alexander MM, Verhoef, Cornelis
Publicado em 2006